One of UMB's top priorities is commercializing innovative technologies discovered by UMB faculty into new therapeutics, vaccines, diagnostics, medical devices, software solutions, and research tools. Successful technology transfer can improve healthcare around the world and create jobs in Maryland. In FY 18, UMB licensed 43 technologies invented by its faculty to private companies, including nine new start-up companies. The President's Entrepreneurial Fellowship is a new initiative designed to give students from UMB and the Smith School of Business hands-on training and experience in commercializing health science discoveries made by UMB faculty. The Fellows will work together as an inter-disciplinary team to bring several of UMB's most promising technologies to market.